7In order to obtain prognostic clinicopathological information, 49 cases of pure ductal carcinoma in situ of the breast (DCIS), were evaluated for the immunohistochemical expression of potential predictor markers including c-erbB-2 oncogene product, p53 protein, oestrogen (ER) and progesterone (PR) receptors, oestrogen-regulated proteins pS2 and cathepsin-D (cath-D), CD44 protein and 67-kDa laminin receptor (MLuC5). Immunohistochemical findings were compared with conventional pathological parameters, clinical findings, and the clinical outcome of the patients. When markers were matched to each other, statistical analyses provided a significant positive correlation between c-erbB-2 overexpression and p53 positivity (P < 0.01) and between ER ...
Although estrogen receptor (ER) content and its clinical significance have been extensively evaluate...
Objective: The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor rec...
CONTEXT AND OBJECTIVE: Breast cancer is thought to derive from progressively aberrant, non-invasive ...
Expression of estrogen (ER) and progesterone receptors, c-erbB-2 oncogene, mutant p53 antioncogene (...
The optimal management of ductal carcinoma in situ (DCIS) is controversial, due in part to our poor ...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
It remains unknown whether erbB2 expression and hormone receptor status predict the invasive potenti...
Background. Several biological markers have been related to prognosis in mammary ductal carcinoma. T...
Introduction: Breast cancer is leading cancer in women, and the incidence of breast cancer in India ...
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ...
SummaryBackgroundBreast cancer patients’ long-term survival rate depends on many factors, such as th...
In a consecutive and unselected series of 178 cases of carcinoma in situ of the breast (CIS), compri...
This study aimed to characterize ductal carcinoma in situ (DCIS) according to human epidermal growth...
This study aimed to characterize ductal carcinoma in situ (DCIS) according to human epidermal growth...
Although estrogen receptor (ER) content and its clinical significance have been extensively evaluate...
Objective: The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor rec...
CONTEXT AND OBJECTIVE: Breast cancer is thought to derive from progressively aberrant, non-invasive ...
Expression of estrogen (ER) and progesterone receptors, c-erbB-2 oncogene, mutant p53 antioncogene (...
The optimal management of ductal carcinoma in situ (DCIS) is controversial, due in part to our poor ...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
It remains unknown whether erbB2 expression and hormone receptor status predict the invasive potenti...
Background. Several biological markers have been related to prognosis in mammary ductal carcinoma. T...
Introduction: Breast cancer is leading cancer in women, and the incidence of breast cancer in India ...
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ...
SummaryBackgroundBreast cancer patients’ long-term survival rate depends on many factors, such as th...
In a consecutive and unselected series of 178 cases of carcinoma in situ of the breast (CIS), compri...
This study aimed to characterize ductal carcinoma in situ (DCIS) according to human epidermal growth...
This study aimed to characterize ductal carcinoma in situ (DCIS) according to human epidermal growth...
Although estrogen receptor (ER) content and its clinical significance have been extensively evaluate...
Objective: The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor rec...
CONTEXT AND OBJECTIVE: Breast cancer is thought to derive from progressively aberrant, non-invasive ...